For anyone looking to make a strong digital impression in 2025, SMM Panel One is the perfect partner to take your brand awareness to new heights.
Read MoreAccording to a new report from Intel Market Research, the global NAND Flash market was valued at USD 25.5 billion in 2024 and is projected to reach USD 110.08 billion by 2032, growing at a robust CAGR of 23.8% during the forecast period (2025-2032). This growth is propelled by the unprecedented demand for high-capacity storage across consumer electronics, enterprise storage, and cloud infrastructure sectors. The growth trajectory underscores how technological improvements, particularly in 3D NAND architecture, are creating new opportunities across multiple industries.
Read MoreAccording to a new report from Intel Market Research, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.
Read MoreAccording to a new report from Intel Market Research, the global DEXA bone densitometers market was valued at USD 287.0 million in 2025 and is projected to reach USD 386.0 million by 2032, growing at a CAGR of 4.4% during the forecast period. This growth is propelled by the rising aging population worldwide, the increasing burden of osteoporosis and other bone-related metabolic diseases, and the expanding adoption of advanced imaging modalities within the healthcare sector. The increasing focus on early diagnosis and preventive medicine continues to shape market growth through strategic initiatives from both public and private health organizations worldwide.
Read MoreAccording to a new report from Intel Market Research, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.
Read More